Nicholas Roma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas Roma has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Bruce Ferraro
Department of Cardiology, St. Luke's University Health Network, Bethlehem, Pennsylvania
3 shared publicationsHarshith Thyagaturu
Department of Cardiovascular Medicine, Heart and Vascular Institute, West Virginia University, West Virginia, USA
2 shared publications- Harshith Thyagaturu
West Virginia University
2 shared publications Joshua Elmer
Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
2 shared publicationsKarthik Gonuguntla
Department of Cardiovascular Medicine, Heart and Vascular Institute, West Virginia University, West Virginia, USA
2 shared publications- Karthik Gonuguntla
West Virginia University, United States
2 shared publications
Latest Publications
- 8 July 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (9) , 2129-2133
Intraprocedural Fibrin Clot Formation During Pulmonary Vein Isolation With a Lattice‐Tip Ablation Catheter
Introduction: Pulsed‐field ablation with a lattice‐tip catheter has emerged as a promising technology for pulmonary vein isolation. We report a case of intraprocedural catheter malfunction with fibrin deposition potentially leading to a transient neurological deficit during ablation despite optimal anticoagulation. Case: A 39‐year‐old man with symptomatic atrial fibrillation and tachycardia‐mediated cardiomyopathy underwent pulmonary vein isolation using the Affera mapping system and Sphere‐9 lattice tip catheter. During the procedure, despite uninterrupted oral anticoagulation and heparin given to meet manufacturer‐recommended activated clotting times, the catheter malfunctioned, and when removed, there was a white solid substance that was seen within the lattice tip. The procedure was stopped prematurely with incomplete pulmonary vein isolation. A pathologist confirmed the white substance was fibrin inside the lattice tip. The patient had symptoms of transient ischemic attack postoperatively and also suffered early recurrence of atrial fibrillation. Conclusion: This case demonstrates fibrin deposition and possible embolic events using the Sphere‐9 lattice tip catheter despite stringent anticoagulation protocols. This highlights the importance of meticulous catheter inspection as well as provides a post‐market complication utilizing this catheter.
- 8 July 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (9) , 2129-2133
Intraprocedural Fibrin Clot Formation During Pulmonary Vein Isolation With a Lattice‐Tip Ablation Catheter
Introduction: Pulsed‐field ablation with a lattice‐tip catheter has emerged as a promising technology for pulmonary vein isolation. We report a case of intraprocedural catheter malfunction with fibrin deposition potentially leading to a transient neurological deficit during ablation despite optimal anticoagulation. Case: A 39‐year‐old man with symptomatic atrial fibrillation and tachycardia‐mediated cardiomyopathy underwent pulmonary vein isolation using the Affera mapping system and Sphere‐9 lattice tip catheter. During the procedure, despite uninterrupted oral anticoagulation and heparin given to meet manufacturer‐recommended activated clotting times, the catheter malfunctioned, and when removed, there was a white solid substance that was seen within the lattice tip. The procedure was stopped prematurely with incomplete pulmonary vein isolation. A pathologist confirmed the white substance was fibrin inside the lattice tip. The patient had symptoms of transient ischemic attack postoperatively and also suffered early recurrence of atrial fibrillation. Conclusion: This case demonstrates fibrin deposition and possible embolic events using the Sphere‐9 lattice tip catheter despite stringent anticoagulation protocols. This highlights the importance of meticulous catheter inspection as well as provides a post‐market complication utilizing this catheter.
- 3 April 2025
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 25 (4) , 443-460
Trimetazidine in Cardiovascular Disease and Beyond: A Comprehensive Review
Trimetazidine is a metabolic modulator that acts as a competitive inhibitor of the terminal enzyme in the β-oxidation pathway to shift energy substrate from free fatty acids to the more oxygen-efficient glucose metabolism. The resulting conservation of cellular adenosine triphosphate generation in the face of ischemia/hypoxia mediates the anti-ischemic efficacy of trimetazidine. Clinically, trimetazidine has been approved as an add-on treatment in patients with symptomatic angina that is poorly controlled with first-line agents or who cannot tolerate the first-line therapy. In addition, trimetazidine has demonstrated antioxidant, cytoprotective, and anti-apoptotic activity with applications beyond angina. The aim of this review was to summarize the mechanism of action and anti-anginal efficacy of trimetazidine and to discuss the putative role of these pleiotropic effects and the evidence behind its application in cardiovascular diseases in general.
- 3 April 2025
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 25 (4) , 443-460
Trimetazidine in Cardiovascular Disease and Beyond: A Comprehensive Review
Trimetazidine is a metabolic modulator that acts as a competitive inhibitor of the terminal enzyme in the β-oxidation pathway to shift energy substrate from free fatty acids to the more oxygen-efficient glucose metabolism. The resulting conservation of cellular adenosine triphosphate generation in the face of ischemia/hypoxia mediates the anti-ischemic efficacy of trimetazidine. Clinically, trimetazidine has been approved as an add-on treatment in patients with symptomatic angina that is poorly controlled with first-line agents or who cannot tolerate the first-line therapy. In addition, trimetazidine has demonstrated antioxidant, cytoprotective, and anti-apoptotic activity with applications beyond angina. The aim of this review was to summarize the mechanism of action and anti-anginal efficacy of trimetazidine and to discuss the putative role of these pleiotropic effects and the evidence behind its application in cardiovascular diseases in general.
- 10 June 2024
- Published by Elsevier in The American Journal of Cardiology
- Vol. 224, 17-19
Prevalence of Phenotypic Hypertrophic Cardiomyopathy Among Student Sports Participants
- 10 June 2024
- Published by Elsevier in The American Journal of Cardiology
- Vol. 224, 17-19
Prevalence of Phenotypic Hypertrophic Cardiomyopathy Among Student Sports Participants
- Open Access
BRASH Syndrome: A Rare Clinical Phenomenon
- 6 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102429
Takotsubo cardiomyopathy and psychiatric illness- insight from National Inpatient Sample (NIS) and National Re-admission Database (NRD) 2016 to 2018
- 6 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102429
Takotsubo cardiomyopathy and psychiatric illness- insight from National Inpatient Sample (NIS) and National Re-admission Database (NRD) 2016 to 2018
- Open Access
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (11) , 710-723
Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Thyagaturu H, et al. Korean Circ J. 2024 Jun;54:e75. https://doi.org/10.4070/kcj.2024.0028
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (11) , 710-723
Open AccessTrends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study
Thyagaturu H, et al. Korean Circ J. 2024 Jun;54:e75. https://doi.org/10.4070/kcj.2024.0028
- 14 December 2023
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 29 (3) , 140-143
Late-onset prosthetic aortic valve stenosis caused by pannus formation
- 14 December 2023
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 29 (3) , 140-143
Late-onset prosthetic aortic valve stenosis caused by pannus formation
- Open Access
- 10 July 2023
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 18, 200196
Trends of antihypertensive use among patients with cancer and hypertension in the United States 2002–2019
- 10 July 2023
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 18, 200196
Open AccessTrends of antihypertensive use among patients with cancer and hypertension in the United States 2002–2019
- Open Access
- 28 June 2023
- Published by IntechOpen
The Field of Cardiac Electrophysiology
Cardiac electrophysiology is a unique and growing field that has made numerous advances in the past 15 years. Specifically, the field is advancing in terms of types of procedures as well as scope of practice. Pacemakers, implantable cardioverter-defibrillators (ICDs), and ablations have been the cornerstone of the field and continue to treat more and more conditions. This chapter will convey a birds-eye view of the types of the procedures in electrophysiology, the indications/contraindications, and the advances in the past 15 years. Additionally, local vs. general anesthesia in these procedures as well as the indication for the type of anesthesia will be discussed. The overall aim of this chapter is to present a unique viewpoint of cardiac electrophysiology as well as elaborate on the various types of anesthesia in this field.
- 28 June 2023
- Published by IntechOpen
Open AccessThe Field of Cardiac Electrophysiology
Cardiac electrophysiology is a unique and growing field that has made numerous advances in the past 15 years. Specifically, the field is advancing in terms of types of procedures as well as scope of practice. Pacemakers, implantable cardioverter-defibrillators (ICDs), and ablations have been the cornerstone of the field and continue to treat more and more conditions. This chapter will convey a birds-eye view of the types of the procedures in electrophysiology, the indications/contraindications, and the advances in the past 15 years. Additionally, local vs. general anesthesia in these procedures as well as the indication for the type of anesthesia will be discussed. The overall aim of this chapter is to present a unique viewpoint of cardiac electrophysiology as well as elaborate on the various types of anesthesia in this field.
- Open Access
- 9 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33527
A Rare Case of St-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus in a Dextrocardia Patient With COVID-19 Infection
Acute coronary syndrome (ACS) is an increasingly common finding among patients presenting with Coronavirus Disease 2019 (COVID-19) pneumonia. While cardiovascular disease alone remains one of the most common causes of death among COVID-19 patients in the United States, its heightened prevalence with COVID-19 pneumonia has been well documented. Here we present the case of a 58-year-old male with an extensive cardiac history including coronary artery disease (CAD) with multiple drug-eluting stents (DES) placed and an episode of cardiac arrest requiring implantable cardioverter defibrillator (ICD) placement. He presented to the Emergency Department originally complaining of chest pain, shortness of breath, and fatigue, and was found to be positive for COVID-19 pneumonia. Cardiac catheterization demonstrated extensive CAD and evaluation for coronary artery bypass grafting (CABG) was warranted. Shortly after, the patient experienced an acute thrombotic episode in the left anterior descending (LAD) coronary artery and underwent successful emergent high-risk percutaneous coronary intervention (PCI) with DES placement. The patient was also found to have a left ventricular thrombus requiring anticoagulation. Despite his complex course, the patient had a very favorable outcome.
- 9 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33527
Open AccessA Rare Case of St-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus in a Dextrocardia Patient With COVID-19 Infection
Acute coronary syndrome (ACS) is an increasingly common finding among patients presenting with Coronavirus Disease 2019 (COVID-19) pneumonia. While cardiovascular disease alone remains one of the most common causes of death among COVID-19 patients in the United States, its heightened prevalence with COVID-19 pneumonia has been well documented. Here we present the case of a 58-year-old male with an extensive cardiac history including coronary artery disease (CAD) with multiple drug-eluting stents (DES) placed and an episode of cardiac arrest requiring implantable cardioverter defibrillator (ICD) placement. He presented to the Emergency Department originally complaining of chest pain, shortness of breath, and fatigue, and was found to be positive for COVID-19 pneumonia. Cardiac catheterization demonstrated extensive CAD and evaluation for coronary artery bypass grafting (CABG) was warranted. Shortly after, the patient experienced an acute thrombotic episode in the left anterior descending (LAD) coronary artery and underwent successful emergent high-risk percutaneous coronary intervention (PCI) with DES placement. The patient was also found to have a left ventricular thrombus requiring anticoagulation. Despite his complex course, the patient had a very favorable outcome.